Track 1: Cell and Gene Therapy

Genes are defined by the NIH as the “basic physical and functional unit of heredity.” We receive these sequences of DNA from our parent as that specified genes is related to such as inheritance. Genes are used for generating all proteins in living beings and serve as the metaphorical instructional manual for our body’s protein. This set of instructions lays the groundwork for the informal building blocks of life cells. Missing of sections and pages in this instruction manual, known as genetic mutations, this may cause serious abnormal functions at the genetic or cellular level. These abnormal functions, if severe enough, can manifest as syndromes or diseases. Traditional small molecule therapies often fall short in treating these types of abnormal functions. Cellular and gene therapies, however, offer promise for untreated syndromes or diseases caused by genetic mutations.

• Replacing a disease-causing gene with a healthy copy of the gene
• Inactivating a disease-causing gene that is not functioning properly
• Introducing a new or modified gene into the body to help treat a disease

Regulatory and Ethical Issues of Therapies Conferences | Immunotherapy Conferences  | Stem Cell Therapies Meeting

Track 2: Cell Science and Stem Cell Research

Stem Cell Research & Therapy is the major domain for translating analysis into stem cell therapies. An international peer-reviewed conference, it publishes high-quality open research access articles with a special stress on basic, translational and clinical research into stem cell therapeutics and regenerative therapies, including animal models and clinical trials. The conference also provides reviews, viewpoints, commentaries, reports and strategies. They are some specified stem cells given below.

• Adult stem cells
• Embryonic stem cells
• Induced pluripotent stem cells
• Cancer stem cells
• Stem cell differentiation, proliferation and migration
• Cell culture and manufacture
• Stem cell therapy/transplantation
• Ethical, legal and social aspects

Stem Cell Therapies Meetings  | Cell and Gene Therapy Conferences | Nanotechnology in Stem Cell Conference

Track 3: Cell Culture and Bioprocessing

Stem cells are the basic materials of body cells from that all different cells will be specialized and functions are generated. Below the proper condition with in the body or a laboratory, stem cells divide to create a lot of cells called daughter cells.

These daughter cells will either become new stem cells (self-renewal) or else become specialized cells with a more specific function, such as blood cells, brain cells, heart muscle cells or bone cells. No different cell with in the body has the natural ability to generate new type of cell.

• Increase understanding of how diseases occur
• Generate healthy cells to replace diseased cells (regenerative medicine)
• Test new drugs for safety and effectiveness

Where do stem cells come from?

• Embryonic stem cells
• Adult stem cells
• Adult cells altered to have properties of embryonic stem cells
• Perinatal stem cells

Cellular Therapies Meetings | Bioengineering Therapeutics Conferences |   Immunotherapy Conferences

Track 4: Stem Cell Therapies

Stem cells are constant cells found in cell living organisms that get separated through a cell division and then gets separate into a particular cell. The two properties of foundational microorganisms which are used to separate them in very body cell are self-restoration and proficiency. Because of their prospective job in different conducts, a foundational microorganism is subjected as inside and outside examination of Extensive Research Science.

• Biology of Human Embryonic Stem Cells.
• Genomics and Genetics in Somatic Cell Biology
• Cell signal in Somatic Cell Differentiation.
• In-vitro culturing of Stem Cells.
• Applications of Somatic Stem Cells.

Stem Cell in Cardiovascular Disease Conferences  | Genetic Vaccines Meeting | Clinical Trials and Research in Cell and Gene Therapies Conferences

Track 5: Stem Cell in Drug Development

 Undefined cell treatment has been opened another way in the territory of medication  disclosure and improvement. Biopharmaceutical organizations have been working in interpreting fundamental utilizations of undefined cell advances in the medication improvement forms in order to diminish the high weakening rate generally arrange sedate applicants, which has been developing at a quick place in the previous decade.

Approach of unformed  microorganism advances has given new expectation to fabricate imaginative cell models. The always developing systems utilized for detachment of human/creature embryonic foundational microorganisms (ESCs), bone marrow-determined mesenchyme developed cells, umbilical line undifferentiated organisms, grown-up tissue-particular neural immature microorganisms and human instigated pluripotent foundational microorganisms (iPSC) have prompted the headway of varied high throughput and combinatorial screening advancements consequently supplementing the a  part of undifferentiated organism models in sedate disclosure.

• Cancer Clinical Trails
• Clinical Research And Bioethics
• Drug Screening Tools
• Stem Cell Biology And Regenerative Medicine
• Drug Safety And Regulations

Regulatory and Ethical Issues of Therapies Conferences |  Molecular Epigenetics Meeting  | Bioengineering Therapeutics Conferences

Track 6: Nanotechnology in Stem Cell

In recent years, stem cell nanotechnology has emerged as a replacement of exciting field. Experimental and Theoretical studies of interaction between nanostructures or nanomaterial’s and stem cells have created nice advances. The importance of nanotechnology, nanostructures, and nanomaterial’s to the elemental developments in stem cells-based therapies for injuries and degenerative diseases has been recognized. In general, the consequences of properties and structure of nanomaterials on the accretion and differentiation of stem cells became a replacement of integrative border in reconstruction medicine and material science

• Nanoparticles: Cell Tracking, And Endocytosis
• Nano vaccines
• Nanomaterial’s And Nano engineering
• Nanotechnology For Genetic Engineering
• Nanotechnology For Creating Stem Cell Niche
• Nanoparticle Toxicity To Stem Cells

Advanced Gene Therapeutics Conference   |  Clinical Trials and Research in Cell and Gene Therapies Meeting   |  Stem Cell in Drug Development Conference

Track 7: Stem Cell in Cardiovascular Disease

Cardiovascular Diseases (CVD) includes congestive heart failure stroke and hypertension, coronary artery disease. Most of these diseases may occur when there is a  less oxygen supply to heart cells / Cardiomyocytes which damaged as being supplied by less oxygen as well as less blood which we  can treated by stem cell therapy by inducing some bone-marrow derived mononuclear cells, umbilical cord blood cells, Mesenchyme stem cells or Cardiac stem cells in to the damaged portion of heart . These cells interspersed in to heart and secrete certain portions and paracrine factors that repair of the damaged area by cardiac tissue Regeneration.

• LQT Syndromes
• Timothy Syndrome
• LEOPARD Syndrome
• Duchene Muscular Dystrophy (DMD)
• Becker Muscular Dystrophy (BMD)
• Hutchinson Gilford Provera (HGPS)

Nanotechnology in Stem Cell Conference  | Bioengineering Therapeutics Conferences  |   Immunotherapy Conferences

Track 8: Epidermis Stem Cell & Cancer Epidemiology

The skin gradually re-establishes itself for the duration of grown-up life, and the hair follicle experiences a never ending cycle of development and decay. Microorganisms (Stem Cell’s) lives in the epidermis and hair follicle guarantee the support of grown-up skin equilibrium and hair recovery; however they likewise take part in the fix of the epidermis after wounds.

• Stem Cells With In Adult Skin Epithelium
• Signalling And Stem Cell Fate Specification In The Skin
• Bone Morphogenetic Protein Signalling
• Notch Signalling

Stem Cell in Cardiovascular Disease Conferences | Regulatory and Ethical Issues of Therapies Conference  | Genetic Vaccines Meeting

Track 9: Novel Stem Cell Therapy

The number of individuals with chronicle wounds has been increasing worldwide due to a fading population, diabetes, obesity, and cardiovascular disease. In the U.S, almost seven million people have chronic skin ulcers. Many restorative approaches have been used. Whatever, the treatment comes out  are not always ideal because of failure to achieve complete wound closure in around 60% of cases, scarring, and high rate of recurrence. However, there is a need of more effective therapies. Stem cells offer promising possibilities. Pre-clinical studies have shown that bone- or adipose tissue-derived mesenchyme stem cells (MSCs) have a competitive advantage over other types of stem cells due to their better defined multi potent differentiating potential, paracrine effects, immune modulatory properties, and safety. Therefore, large controlled clinical trials are needed to examine the capabilities of MSCs in humans and to assess their safety profile. In this review, we highlight emerging treatments in tissue regeneration and repair and provide some perspectives on how to translate current knowledge about stem cells-both multi potent and pluripotent-into the clinical approach for treating patients on heal wounds

• Novel Stem Cell Therapy For Knees
• Novel Stem Cell Therapy For Arthritis
• Novel Stem Cell Therapy For Cancer
• Novel Stem Cell Therapy For Hair loss

Cellular Therapies Meetings | Bioengineering Therapeutics Conferences |  Immunotherapy Conferences

Track 10: Cellular Therapies

Cell therapy (also called cellular transplantation, cell therapy, or cytotherapy) is a therapy in which possible cells are injected, implant or embed into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.

Cell therapy commenced in the nineteenth century when scientists experimented by injecting animal material in a try to prevent and treat illness. However, such try didn’t produced any  positive benefit, the next research was  found in the mid twentieth century that human cells could be used to help prevent the human body rejecting transplanted organs, leading in time to successful bone marrow transplantation has become common practice in treatment for patients that have compromised bone marrow after disease, infection, radiation or chemotherapy. 

• Allogeneic Cell Therapy
• Autologous Cell Therapy
• Xenogeneic Cell Therapy

Cell and Gene Therapy Meeting  | Cell Science and Stem Cell Research  | Nanotechnology in Stem Cell Conference

Track 11: Advanced Gene Therapeutics

   The capability to make specific modifications to the human gene has been an objective in medical since; gene is the recognition of the basic unit for heredity. Therefore, gene therapy is defined as the capability of genetic improvement through the correction of modified genes or specific modifications that target therapeutic treatment. This therapy became possible through the advances of genetics and bioengineering that enabled manipulating vectors for delivery of extra chromosomal material to target cells. One of the major focuses on this technique is the optimization of delivery vehicles (vectors) that are mostly plasmas, unstructured or viruses. These viruses are more often investigated due to their excellence of infected cells and inserting their genetic material.

• Substitution of the adenosine deaminize deficiency
• Substitution of α 1-antitrypsin
• Improvement of immune function
• Tumour removal
• Chemo protection
• Enzymatic substitution
• Cytokine release

  Stem Cell Therapies Meeting  |  Regulatory and Ethical Issues of Therapies Conference  |  Clinical Trials and Research in Cell and Gene Therapies Meetings

Track 12: Immunotherapy

   Immunotherapy is considered as a type of cancer treatment that helps your immune system to fight against cancer. The immune system helps your body to fight with infections and other diseases. It is consists of organs and white blood cells and tissues of the lymph system.

Immunotherapy is a type of biological therapy. Organic therapy is a type of treatment that we use from the substances made from living organisms to treat cancer.

• Immune checkpoint inhibitors
• T-cell transfer therapy
• Monoclonal antibodies
• Immune system modulators

Stem Cell Therapies Meetings  | Regulatory and Ethical Issues of Therapies Conference | Nanotechnology in Stem Cell Conference

Track 13: Cancer Therapies

   There are many types of cancer treatment. Which types of treatment that you can prescribe will depend on the type of cancer that you have and how advanced it is. Some people who were facing with cancer will have only one treatment. But most people have a rear case in combination of treatments, such as surgery with chemotherapy and also with radiation therapy. When you need a treatment for cancer, you have a lot to think and learn about. It is normal to feel affected and confused. But, talking with your doctor and learning about which type of treatment you may have can help you feel better and can control the fear.

• Surgery
• Radiation Therapy
• Chemotherapy
• Immunotherapy
• Targeted Therapy
• Hormone Therapy
• Stem Cell Transplant
• Precision Medicine

Stem Cell in Cardiovascular Disease Conferences  |  Genetic Vaccines Meeting   | Clinical Trials and Research in Cell and Gene Therapies Conferences

Track 14: Nano-Therapy

      At the present scenario   Cancer therapies are not basing on surgery, radiation, and chemotherapy. Because all these three methods cause a risk damage to normal tissues or incomplete destruction of the cancer. Nano- therapy means to target chemotherapies and also collectively to cancerous cells and neoplasms, guide in surgical resection of tumour and enhance the therapeutic competence of radiation-based and the other current based treatment methods. All these together can decrease the risk to the patient and an increased probability of survival.

• Delivering Chemotherapy
• Nano-enabled Immunotherapy
• Delivering or Augmenting Radiotherapy
• Delivering Gene Therapy

Human Gene Therapy Conference   |   Nanotechnology in Stem Cell Conference  | Molecular Epigenetics Meeting

Track 15: Human Gene Therapy

Human gene therapy and its function for the treating the human genetic disorders, such as cystic fibrosis, cancer, and other diseases, are considered. Gene therapy is defined as a technique in which a functioning gene is stuck in into a human cell to correct a genetic error or else to introduce a new functioning to the cell. Many methods, including viral vectors and non-viral vectors, have been developed for both ex vivo and in vivo gene transfer into cells. There are several safety and ethical issues related to manipulating the human gene that need to be resolved. Current gene therapy efforts focus on gene insertion into stem cells only. The current human gene project provides the sequences of a vast number of human genes, leading to the identification, characterization, and understanding of genes that are responsible for many human diseases.

• Replacing a disease-causing gene with a healthy copy of the gene
• Inactivating a disease-causing gene that is not functioning properly
• Introducing a new or modified gene into the body to help treat a disease
• Plasmid DNA.
• Viral vectors
• Bacterial vectors
• Human gene editing technology
• Patient-derived cellular gene therapy products

Stem Cell in Cardiovascular Disease Conferences  | Genetic Vaccines Meeting   | Clinical Trials and Research in Cell and Gene Therapies Conferences

Track 16: Molecular Epigenetics

    Epigenetics is rising to eminence in biology as a mechanism by which environmental factors have intermediate-term effects on gene expression without changing the underlying genetic sequence. It can occur through the specific methylation of DNA bases and modification of histones. There are wide-feeding implications for the gene-environment contest and epigenetic mechanisms are causing a revaluation of many traditional concepts such as heritability. The reversible nature of epigenetics also provides conceivable treatment or prevention prospects for diseases previously thought hard-coded into the gene. Therefore, we consider how growing knowledge of epigenetics is altering our understanding of biology and medicine, and its implications for future research.

• Covalent modifications
• RNA transcripts
• MicroRNAs
• mRNA
• sRNAs
• Prions
• Structural inheritance
• Nucleosome positioning
• Genomic architecture

Regulatory and Ethical Issues of Therapies Conferences  |   Immunotherapy Conferences   |  Stem Cell Therapies Meeting

Track 17: Genetic Vaccines

Vaccination consists of appealing the immune system with a contagious agent, or components of a contagious agent, modified in such a manner that there is no harm or disease, but securing that when the host is resisted with that contagious agent, the immune system can appropriately neutralize it before it causes any illness. A hundred years vaccination has been bring out  by one of two match: either introducing specific antigens against which the immune system reacts directly; or introducing live attenuated infectious agents that replicate within the host without causing disease synthesize the antigens that subsequently prime the immune system.

• No risk for infection
• Antigen presentation by both MHC class I and class II molecules
• Polarise T-cell response toward type 1 or type 2
• Immune response focused on the antigen of interest
• Ease of development and production
• Stability for storage and shipping
• Cost-effectiveness
• Obviates need for peptide synthesis, expression and purification of recombinant proteins and use of toxic adjuvants
• Long-term persistence of immune gen

Nanotechnology in Stem Cell Conference  | Bioengineering Therapeutics Conferences  |   Immunotherapy Conferences

Track 18: Bioengineering Therapeutics

Therapeutics Engineering assembles understanding of bodily responses to imputable materials and drug delivery devices. These focus on the biomaterial selection and fusion and also in depth study of drug design, manufacturing, and delivery. We will be getting trained in Nano-materials, material properties, transport phenomena, biochemical engineering, and metabolic engineering. Application areas include analyse therapeutics, biomimetic, and drug delivery systems.

• Advancing technologies to detect and differentiate disease states and treatment responses (i.e., biomarkers) rapidly and precisely
• Developing low-cost sensors that detect subtle, early changes in health status, allowing for more rapid, effective interventions
• Synthesizing injectable microstructure biomaterials to reduce functionally debilitating scarring
• Creating methods and devices to deliver drugs across biological barriers, and to precisely target therapies to specific tissues and cells
• Building and miniaturizing fully implantable, bio artificial devices to carry out the natural functions of failed organs

• Building a solution for kidney failure
• Drug delivery for a leading cause of blindness
• Speeding genetic analysis of individual cells for disease biomarkers
• Delivering targeted, personalized cancer therapy to metastatic tumours
• Developing metabolic imaging technologies to detect cancer biomarkers
• Using microstructures to reduce debilitating scars after heart attacks

Regulatory and Ethical Issues of Therapies Conferences  |   Immunotherapy Conferences   |  Stem Cell Therapies Meeting

Track 19: Clinical Trials and Research in Cell and Gene Therapies

Almost every cell and gene therapy the clinical trial is dissimilar in some way. Working with living organisms presents new and dissimilar challenges to the traditional clinical trial model. With over 400 decades CGT professionals globally, ICON has developed tools and best practices to transform CGT trial design and implementation. From site selection to study start up through implementation, ICON supply project management, clinical services, product-specific logistics solutions, data flow, regulatory strategy and central laboratory services.

Advanced Gene Therapeutics Conference   |  Clinical Trials and Research in Cell and Gene Therapies Meeting   |  Stem Cell in Drug Development Conference

Track 20: Regulatory and Ethical Issues of Therapies.

The U.S. Food and Drug Administration's (FDA's) new Paediatric Rule makes it more likely that children will receive improved treatment, because physicians will have more complete information on how drugs affect children and the suitable  doses for each age group (FDA, 1998e). The rule also allows FDA to require industry to test already marketed products in studies with paediatric populations in certain fascinating circumstances, such as when a drug is commonly prescribed for use in children but when the absence of adequate testing and labelling could be significant risks. The aim of this session is to examine many interrelated legal and regulatory issues, as well as the interrelated social and ethical concerns, in the evaluation of the effects of drugs and biologics on paediatric populations.

• Anchoring Studies to "Minimal Risk"
• Current Regulations Guiding Clinical Research
• Placebo-Controlled Trials
• Consent, Assent, and Determination of Risk

Cellular Therapies Meetings | Bioengineering Therapeutics Conferences |   Immunotherapy Conferences

Track 21: Cell Biology:

Cell biology is the study of cell structure and function, and it spins around the concept that the cell is the basic unit of life. Centering on the cell permits a detailed understanding of the tissues and organisms that cells compose. A few organisms have only one cell, whereas others are organized into agreeable groups with huge numbers of cells. On the entire, cell biology centers on the structure and work of a cell, from the foremost common properties shared by all cells, to the special, profoundly complex functions particular to specialized cells.

Track 22: Regenerative Medicine:

Regenerative Medicine, the application of treatments developed to replace tissues damaged by injury or malady. These medicines may include the utilize of biochemical procedures to initiate tissue recovery specifically at the site of damage or the utilize of transplantation methods utilizing separated cells or stem cells, either alone or as a portion of a bio-artificial tissue.

Track 23: Cell Biology:

Cell, in biology, the fundamental membrane-bound unit that contains the elemental molecules of life and of which all living things are composed. A single cell is frequently a total living being in itself, such as a bacterium or yeast. Other cells secure specialized capacities as they develop. These cells coordinate with other specialized cells and ended up building squares of huge multicellular life forms, such as humans and other animals.

 

Advantages of Participating at our Webinar

• The advantages of the Speaker and abstract pages are created in Google on your profile under your name would get worldwide visibility.
• Our comprehensive online advertising attracts 30000+ users and 50000+ views to our Library of Abstracts, which takes researchers and speakers to our webinar.
• Meet with hundreds of like-minded experts who are pioneers in Cell and Gene therapy and share ideas.
• All participants in the webinar would have a different reason to participate with distinguished speakers and renowned keynote speakers in one-to-one meetings.
• A rare opportunity to listen what the world's experts are learning about from the world's most influential researchers in the area of cell therapy at our Keynote sessions.
• Cell and Gene therapy Summit intensive webinar schedule, you will acquire experience and expertise in strategic gift preparation that is worth its weight golf, forming an impressive array of recognised professionals.
• Best Poster Award nominations.
• Award for Outstanding Young Researcher.
• Group Registration Advantages.

Benefit of Association for Collaborators

• Nobody has these massive visitors to Cell and Gene therapy in the world, this is the best forum to highlight society.
• Creating long-lasting peer relationships.
• In our webinar banner, website and other proceedings, branding and marketing material, promotional content and your Organization logo will increase your number of subscribers/members by 40%.
• The exposure of our event to your Company listing in the Global Business forum will have a great effect on your association.
• Your representatives can network to update their knowledge and understanding of your organisation and services with key webinar delegates.
• Cell and Gene therapy advertising materials such as posters, brochures, pamphlets, services that will be circulated to hospitals, universities, society and researchers will be integrated with information.

Benefits of Participation for Speaker

• Worldwide appreciation of the profile of Researchers.
• Obtain credits for professional growth.
• Explore the latest of cutting edge analysis.
• Make long-term bonds at social and networking activities.
• An ability to advertise one page in the distribution of abstract books and flyers that ultimately gets 1 million views and adds great value to your research profile.
• Learn a transition beyond your area of interest to learn more about new subjects and studies away from your subject of cell and Gene therapy.
• We have distinctive learning and enjoyable integration into a single package.

Benefits of Participation for Delegate

• Professional Development-Improve understanding and knowledge.
• Attendance at webinars supports revive and excite delegates.
• Your involvement in our webinar will help with a new methodology and ideology that can be used to broaden the outcomes of businesses or industries.

Opportunities for Cell and Gene therapy Summit researchers and experts in the same field to meet and exchange new ideas through an online webinar

Benefit of Participation for Sponsor

• Exposure to the international environment would increase the possibility of new companies.
• Opportunity to demonstrate your company's latest technologies, new products, or service your business to a wide range of international participants.
• Increase business by our webinar participants through lead generation.
• It takes a lot of time, effort and drive to create a successful company, so it's always nice to have a network of colleagues and associates to draw energy from individuals who share a common drive and objective.
• Webinars in neurology provide opportunities for more attention and contemplation that could help you move your company to the next stage.
• Benchmarking main organization plans and moving it forward.
• Get feedback from trustworthy people at our webinar to your company questions and challenges.
• On our webinar banner, website and other proceedings, branding and marketing content, the advertising logo of your company.